Research

Hormonal

In patients with type 2 diabetes, higher diabetes severity (measured by the Individualized Metabolic Surgery score) is associated with significantly lower total body weight loss from semaglutide treatment.

If you have type 2 diabetes, your expected weight loss from semaglutide depends on how severe your diabetes is. Those with milder diabetes (better blood sugar control, no insulin) tend to lose more weight (around 8%) than those with severe diabetes (often on insulin, higher HbA1c), who lose less (around 5.5%). However, the medication still offers important health benefits for blood sugar and heart health regardless of the amount of weight lost, so it remains a recommended treatment for severe cases.

GoodQualifiesHIGH confidence
In our cohort, lower IMS severity was associated with more weight loss in patients with obesity and T2D.
Wissam Ghusn et al. · EClinicalMedicine · 2024

Why this rating

Retrospective multicenter cohort study with a decent sample size (n=297) and statistical significance, but limited by retrospective design and lack of randomization.

Source

Weight loss outcomes with semaglutide based on diabetes severity using the individualized metabolic surgery score

Wissam Ghusn et al. · EClinicalMedicine · 2024

DOI 10.1016/j.eclinm.2024.102625

cohort · n=297Cited 8×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →